ADVANCE-ON
Trial Details
- Trial statusCompleted
- Chief InvestigatorJohn P Chalmers
- SponsorThe George Institute, Australia
- ISRCTN numberN/A
- View clinicaltrials.gov website
- View dedicated study website
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study
Design and Objective
The study is designed to determine the long term, post trial effects of the two interventions studied in ADVANCE (routine blood pressure lowering with perindopril-indapamide as compared with placebo and intensive gliclazide-MR based glucose control as compared to standard guideline based glucose control) in individuals with type 2 diabetes at high risk of cardiovascular events. http://www.nejm.org/doi/full/10.1056/NEJMoa1407
Key inclusion criteria
•Participated in ADVANCE trial •Ability to provide informed consent
Study Disclaimer Statement
TBC